Hope S. Rugo: CALGB 40502/NCCTG N063H

Hope Rugo, Oncologist + Shelley Hwang, Surgeon (v2)Подробнее

Hope S. Rugo, et al.Подробнее

Results of the CALGB 40502 Study in TNBCПодробнее

Message from Dr Hope Rugo on COVID 19 and Cancer PatientsПодробнее

SABCS2014: CALGB 40603/150709 (Alliance): William M. SikovПодробнее

Dr. Rugo on Chemotherapy for Metastatic Breast CancerПодробнее

Hope S. Rugo on the Approval of the Cooling CapПодробнее

Hope S. Rugo: First efficacy results from the I - SPY 2 TRIALПодробнее

5-Year Follow-Up of CALGB 40502 Study in TNBCПодробнее

Dr. Rugo on SWISH Trial for HR-Positive Breast CancerПодробнее

Dr. Rugo on Pathway Blockade in Breast CancerПодробнее

Dr. Rugo on Guidelines for the Treatment of Metastatic Breast CancerПодробнее

Dr. Rugo on Hormone Therapy for Patients With Breast CancerПодробнее

Dr. Hope Rugo Examines Angiogenesis Inhibition for Advanced Breast CancerПодробнее

Dr. Hope Rugo on the First-line Superiority of Paclitaxel for Advanced Breast CancerПодробнее

Five-Year Dosing, Efficacy Results for Nab-Paclitaxel in TNBCПодробнее

Dr. Rugo Discusses Guidelines for Metastatic Breast Cancer ManagementПодробнее

Hope Rugo on Managing Effects From Ovarian Suppression in Patients With Breast CancerПодробнее

Hope Rugo, MD: Chemotherapy Agents and Breast Cancer TreatmentПодробнее